ClinicalTrials.Veeva

Menu

"Parkinson AKTIV - Non-pharmacological Treatments in an Innovative Parkinson's Network" (ParkinsonAKTIV)

U

University Hospital Muenster

Status

Enrolling

Conditions

Parkinson Disease

Treatments

Other: Coordination through the online platform "JamesAKTIV"

Study type

Interventional

Funder types

Other
Industry

Identifiers

NCT05251298
2021-356-f-S
01NVF19002 (Other Grant/Funding Number)

Details and patient eligibility

About

The purpose of this study is to evaluate the efficacy of an online platform that allows neurologists and therapists to exchange therapy recommendations, communicate assessments and plan physical therapy, occupational therapy as well as speech and swallowing therapy for their patients.

Full description

The aim of this study is to enroll 185 patients in the intervention group and 185 patients in the control group. Patients in the intervention group come from the same region (Münsterland), the control group will consist of patients outside this region. The patients in the intervention group undergo therapies planned and coordinated through the online platform for 12 months. The patients in the intervention group will be evaluated using the PDQ-39, UPDRS, H&Y as well as Schwab & England. The patients in the control group will be evaluated using the PDQ-39.

Enrollment

370 estimated patients

Sex

All

Ages

30+ years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria (Intervention Group):

  • Idiopathic Parkinson's Disease with pharmacological treatment
  • 30 years old or older
  • place of residence: Münsterland, Tecklenburger Land, Kreis and Stadt Osnabrück
  • sufficient knowledge of the German language, should be able to understand the consent form

Exclusion Criteria:

  • severe cognitive deficits
  • Atypical Parkinsonian Disorders
  • participation in other studies

Trial design

Primary purpose

Health Services Research

Allocation

Non-Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

370 participants in 2 patient groups

Intervention group
Active Comparator group
Description:
Patients in the intervention group come from the same region (Münsterland) and will undergo therapies coordinated through the online platform.
Treatment:
Other: Coordination through the online platform "JamesAKTIV"
Control group
No Intervention group
Description:
Patients in the control group will undergo their usual therapies as prescribed by their neurologists.

Trial contacts and locations

1

Loading...

Central trial contact

Tessa Huchtemann, Medical Degree; Tobias Warnecke, Medical Degree, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems